Amazing science and talented people! - Recensione dipendente - Head of Science presso Bit Bio

5,0
16 apr 2024
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Joining bit.bio has been an extraordinary journey of professional growth and personal fulfillment. From day one, I was immersed in an environment where innovation and ambition aren’t just encouraged—they’re the foundation of everything we do. The company stands at the forefront of synthetic biology, aiming to transform medicine through its pioneering work in coding human cells. The mission to democratise cell types and create a new generation of cures for patients around the world is not only inspiring but also provides a deep sense of purpose to our daily tasks. The culture at bit.bio is truly unique. Collaboration and inclusivity are not just buzzwords here; they are practiced daily, fostering a workspace where diverse ideas thrive, and everyone’s contribution is valued. The leadership team is remarkably transparent, approachable, and supportive, ensuring that we’re not only aware of the company’s strategic direction but also understand our role in achieving those goals. Professional development is a priority, with ample opportunities to learn, grow, and take on new challenges. Whether it’s through formal training, cross-functional projects, or the chance to work with cutting-edge technologies, I feel constantly driven to expand my skills and knowledge. In summary, working at bit.bio offers a rare combination of making a real impact on the future of medicine, career growth, and being part of a supportive and innovative community. It’s a place for those who are passionate about making a difference and eager to push the boundaries of science and technology.

Svantaggi

Working at bit.bio presents a unique blend of excitement and challenges, emblematic of what one might expect from a pioneering startup at the cutting edge of synthetic biology. As we navigate the complexities of coding human cells to revolutionise medicine, we are inevitably faced with the teething challenges characteristic of any ambitious startup. One such challenge is the pace of change. Projects and priorities can shift rapidly as we respond to new scientific discoveries or business opportunities. While this dynamism is thrilling and fosters a culture of agility and innovation, it requires a level of adaptability and resilience that may not suit everyone. Despite these challenges, the spirit of collaboration and shared purpose at bit.bio is palpable. We are not just a team but a community, united in our mission to unlock a new era of medicine. In essence, working at bit.bio is about building something transformative together. The journey is fraught with challenges inherent to pioneering science and a rapidly evolving business landscape. This is why it is exciting to work here!

avatar
Risposta di Bit Bio
2y
Thank you for taking the time to leave such a detailed review of bit.bio. It is great that you have had such a fulfilling career here, and that you recognise that whilst the pace of working at bit.bio is indeed greater than some organisations, it is all for a worthy cause. And because of this, we do always ensure our employees are coping, and have mechanisms in place such as mental health training and EAPs to support them.

Esplora altre recensioni su Bit Bio

1,0
13 ago 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Many scientists are highly skilled and dedicated to their work and most facilities are well-equipped

Svantaggi

bit.bio used to be a good company with a strong mission, but the recent leadership changes have made it clear there is no stable strategy or direction. In just two months, the company went through three different CEOs — even governments don’t rotate leaders that fast. In both 2024 and 2025, roughly 20–30% of the workforce was made redundant. These cuts were followed almost immediately by hiring sprees and promotions at senior management level, which made little sense. Internal roles were often tailored to people already chosen to stay, and redundancy packages were inconsistent. What’s worse, company documents from as far back as November 2023 indicated financial instability, yet new hires were still brought on — some only to be let go within weeks or months. Promotions are almost exclusively for senior-level staff; research assistants, even those with 3–6 years of experience, remain stuck in the same role without salary reviews, and requests for progression are met with vague, dismissive explanations. The lack of strategic clarity is striking. For example, in 2024 the company invested in building a cell therapies department, only to make the entire team redundant within months, then shifted focus to commercial hiring, and now seems to be exploring media component development. The result is a constant feeling of uncertainty: offices are half-empty, morale is low, and employees feel undervalued. HR has also not helped the situation — redundancies were handled with minimal transparency and support, with packages kept to the bare minimum. Overall, bit.bio has gone from a place with real potential to one marked by instability, unclear priorities, and poor treatment of staff.

5
avatar
Risposta di Bit Bio
9mo
Thank you for taking the time to share your feedback. We’re glad you highlighted the dedication and expertise of our scientific teams and the strength of our facilities — these remain some of our greatest assets. We also want to acknowledge your concerns regarding leadership transitions and organisational changes. The past two years have been a very challenging time across the biotech sector, with many companies facing closures or significant restructuring. At bit.bio, we have had to make difficult decisions to secure the company’s future and focus resources where they will have the greatest long-term impact. Regarding redundancies, it is important to clarify that while HR plays a supporting role, these decisions are made at the executive level. HR’s responsibility is to ensure the process is carried out fairly, respectfully, and with support for those affected. These processes were conducted with transparency, and as much detail as could be shared at the time was communicated directly by the Executive team. Given the financial status of the organisation, we were unable to provide enhanced packages, but all statutory requirements were met. In addition, we offered LinkedIn learning training, CV and interview support, and proactively shared CVs with other organisations to help colleagues transition into new opportunities. We understand the impact such changes have on morale and on individuals personally. While these steps cannot take away the difficulty of redundancies, they reflect our commitment to supporting colleagues as best we can under the circumstances. bit.bio remains deeply committed to its mission of accelerating biomedical innovation through cell coding technology, and we continue to focus on building a sustainable path forward where employees feel valued and supported.
4,0
30 mar 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

A growth company with fast paced environment bringing good exposure.

Svantaggi

High volatility based on the funding environment

avatar
Risposta di Bit Bio
2mo
Thank you for your feedback. We're glad to hear that you’ve found value in the fast-paced, growth-oriented environment at bit.bio and the exposure it provides. We also appreciate your perspective on the challenges related to volatility in the funding environment. While this has been a factor in the past, we have since secured additional funding, which puts us in a more stable position. That said, we remain mindful of the responsibility that comes with this and are focused on deploying it thoughtfully to support our long-term goals and the sustainability of the business.
Vedi recensioni per: Utile|Valutazione|Data|Tutto